Resolutions of Annual General Meeting of Shareholders The

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Resolutions of Annual General Meeting of Shareholders

The following resolutions have been adopted at the Annual General Meeting of Shareholders of Panevėžio statybos trestas AB taken place on 30 April 2015:

Draft Resolutions of Annual General Meeting of Shareholders of Panevėžio statybos trestas AB:

  1. The conclusions of the audit regarding the financial statement and annual report of the Company for the year 2014.

Information heard.

  1. The annual report of the Company for the year 2014.

Information heard.

  1. Approval of the consolidated statement and the set of individual financial statements of Panevėžio statybos trestas AB for the year 2014.

The consolidated statement and the set of individual financial statements of Panevėžio statybos trestas AB for the year 2014 have been approved.

  1. Distribution of profit (loss) of the Company for the year 2014.

The following distribution of profit (loss) of Panevėžio statybos trestas AB for the year 2014 has been approved:

      4.1. Undistributed profit (loss) of the previous financial year at the end of the accounting financial year – 108 737 798 Lt (31 492 643 EUR);

Dividends paid – 0 Lt (0 EUR);

Net profit (loss) of the accounting financial year – 3 728 807 Lt (1 079 937 EUR);

Profit (loss) of the accounting financial year unrecognized in profit (loss) statement 551 267 Lt (159 658 EUR);

Transfers from reserves - 0 Lt (0 EUR);

Contributions of shareholders to cover the loss of the Company (in case of the shareholder decision to cover all or a part of loss) - 0 Lt (0 EUR);

Profit (loss) available for distribution in total – 113 017 872 Lt (32 732 238 EUR);

a part of profit to the required reserve - 0 Lt (0 EUR);

a part of profit to the reserve for the acquisition of own shares - 0 Lt (0 EUR);

a part of profit to other reserves - 0 Lt (0 EUR);

a part of profit for dividend paying  - 3 725 916.48 Lt (1 079 100 EUR);

a part of profit for annuity (bonuses) for the members of the Board and Supervisory Board, premium pays for employees and other purposes – 745 761 Lt (215 987 EUR);

The undistributed profit (loss) at the end of the accounting financial year transferred to the next financial year – 108 546 194.52 Lt (31 437 151 EUR).

       4.2. To allocate 220 577.20 Lt (63 883.57 EUR) from the part of profit for annuity (bonuses) for the members of the Board and Supervisory Board, premium pays for employees and other purposes – 745 761.00 Lt (215 987.31 EUR) to Remigijus Juodviršis, the Chairman of the Board of Panevėžio statybos trestas AB. To obligate Remigijus Juodviršis, the Chairman of the Board, to appropriate the remaining amount of 525 183.80 Lt (152 103.74 EUR) for annuity (bonuses) for the members of the Board and Supervisory Board, premium pays for employees and other purposes to the members of the Board of Panevėžio statybos trestas AB.

To appropriate dividends in the amount of 0.2278848 Lt (0.066 EUR) for each ordinary share of Panevėžio statybos trestas AB of the par value of 1 Litas. The total amount to be appropriated for dividends is 3 725 916.48 Lt (1 079 100 EUR).

  1. Election of the members for the audit committee.

The following members have been elected to the audit committee:

  • Irena Kriaučiūnienė (as an independent member)
  • Lina Ragelienė
  • Regina Sukarevičienė
  1. Election of the member for the Board.

Audrius Balčėtis has been elected to the Board of Panevėžio statybos trestas AB.

Dalius Gesevičius

Managing Director

Panevėžio statybos trestas AB

Information

Phone: (+370 45) 505 503

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading